Company: BIAF
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001641172-25-025247
Chunk: 59

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-22
Form: DRS
Chunk 59
---
cement letter agreement that we entered into with a certain holder of existing warrants, in exchange for such holder’s exercise for cash of certain of their October 2024 Warrants and August 2024 Warrants at a reduced exercise price of $0.23.

Item 16. Exhibits.

The list of exhibits in the Exhibit Index to this registration statement is incorporated herein by reference.

Item 17. Undertakings.

The undersigned registrant hereby undertakes:

| (1) | to                                                                                                                          
 file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement; |

| (i) | to                                                                                             
 include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended; |

| (ii)  | to                                                                                                                                               
 reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective 
 amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration     
 statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of             
 the securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum           
 offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if,          
 in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth          
 in the “Calculation of Registration Fee” table in the effective registration statement; and                                                      |
| (iii) | to                                                                                                                                               
 include any material information with respect to the plan of distribution not previously disclosed in this registration statement or             
 any material change to such information in this registration statement;                                                                          |

provided, however, that the undertakings set forth in paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended, that are incorporated by reference in this registration statement or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of this registration statement;

| II